Nudol

Nudol

SCHEMBL3971615

COc1c(O)cc2ccc3cc(O)ccc3c2c1OC

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 1/20 0.54
TUBB P07437 1/20 0.54
TUBA3C P0DPH7 1/20 0.54
TUBA1B P68363 1/20 0.54
TUBA4A P68366 1/20 0.54
TUBB4B P68371 1/20 0.54
TUBB3 Q13509 1/20 0.54
TUBB2A Q13885 1/20 0.54
TUBB8 Q3ZCM7 1/20 0.54
TUBA3E Q6PEY2 1/20 0.54
TUBA1A Q71U36 1/20 0.54
TUBA1C Q9BQE3 1/20 0.54
TUBB6 Q9BUF5 1/20 0.54
TUBB2B Q9BVA1 1/20 0.54
TUBB1 Q9H4B7 1/20 0.54
ESR1 P03372 2/20 0.50
ESR2 Q92731 2/20 0.50
ABL1 P00519 2/20 0.48
KDM4E B2RXH2 2/20 0.48
GAA P10253 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5804555 0.85 TUBB4A (0.64) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL29770963 0.81 ESR1 (0.51) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL5804536 0.81 ESR1 (0.51) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL27939366 0.81 MAPT (0.52) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL28632540 0.80 ESR1 (0.46) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL9623607 0.79 ESR1 (0.75) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL11508300 0.79 MCL1 (0.70) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL29409811 0.78 ABL1 (0.53) ESR1ESR2ABL1KDM4EGAA
SCHEMBL22657846 0.78 ABL1 (0.53) ESR1ESR2ABL1KDM4EGAA
SCHEMBL29409808 0.78 ABL1 (0.53) ESR1ESR2ABL1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215908-A1 TOLL LIKE RECEPTOR (TLR) SIGNALING ANTAGONIST RELIANCE LIFE SCIENCES PVT. LTD. (IN) 2009-08-27 US claimed
WO-2009047791-A2 TOLL LIKE RECEPTOR (TLR) SIGNALING ANTAGONIST RELIANCE LIFE SCIENCES PVT. LTD. (IN) 2009-04-16 WO claimed
CN-108497548-A A kind of stem of noble dendrobium medicinal extract and its application in cigarette 河南中烟工业有限责任公司 2018-09-07 CN disclosed
US-20090215908-A1 TOLL LIKE RECEPTOR (TLR) SIGNALING ANTAGONIST RELIANCE LIFE SCIENCES PVT. LTD. (IN) 2009-08-27 US disclosed
US-20090215908-A1 TOLL LIKE RECEPTOR (TLR) SIGNALING ANTAGONIST RELIANCE LIFE SCIENCES PVT. LTD. (IN) 2009-08-27 US disclosed
US-20090215908-A1 TOLL LIKE RECEPTOR (TLR) SIGNALING ANTAGONIST RELIANCE LIFE SCIENCES PVT. LTD. (IN) 2009-08-27 US disclosed
WO-2009047791-A2 TOLL LIKE RECEPTOR (TLR) SIGNALING ANTAGONIST RELIANCE LIFE SCIENCES PVT. LTD. (IN) 2009-04-16 WO disclosed
WO-2009047791-A2 TOLL LIKE RECEPTOR (TLR) SIGNALING ANTAGONIST RELIANCE LIFE SCIENCES PVT. LTD. (IN) 2009-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215908-A1 TOLL LIKE RECEPTOR (TLR) SIGNALING ANTAGONIST TLR4, TLR5, TLR1 TUBB4A 2543/4885TUBB 2809/4885TUBA3C 4071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.